Dare Bioscience, Inc. (DARE): Net Income
-$13.40M
Year ended 2025-12-31
-$10.99M
Trailing 12 months to 2026-06-30
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$13.40M | n/m | 2026-03-26, From 2025-01-01 |
| 2024-12-31 | -$4.05M | n/m | 2026-03-26, From 2024-01-01 |
| 2023-12-31 | -$30.16M | n/m | 2025-03-31, From 2023-01-01 |
| 2022-12-31 | -$30.95M | n/m | 2024-03-28, From 2022-01-01 |
| 2021-12-31 | -$38.70M | n/m | 2023-03-30, From 2021-01-01 |
| 2020-12-31 | -$27.40M | n/m | 2022-03-31, From 2020-01-01 |
| 2019-12-31 | -$14.26M | n/m | 2021-03-30, From 2019-01-01 |
| 2018-12-31 | -$16.74M | n/m | 2020-03-27, From 2018-01-01 |
| 2017-12-31 | -$11.50M | n/m | 2019-04-01, From 2017-01-01 |
| 2016-12-31 | -$672.7K | n/m | 2018-03-28, From 2016-01-01 |
| 2015-12-31 | -$39.59M | n/m | 2017-06-13, From 2015-01-01 |
| 2014-12-31 | -$23.34M | n/m | 2017-06-13, From 2014-01-01 |
| 2013-12-31 | -$17.14M | n/m | 2016-03-10, From 2013-01-01 |
| 2012-12-31 | -$22.10M | n/a | 2015-03-19, From 2012-01-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| Dare Bioscience, Inc. (DARE) | 2025-12-31 | -$13.40M | n/m |
| 60 Degrees Pharmaceuticals, Inc. (SXTP) | 2025-12-31 | -$7.37M | n/m |
| Shattuck Labs, Inc. (STTK) | 2025-12-31 | -$48.81M | n/m |
| Bespoke Extracts, Inc. (BSPK) | 2024-12-31 | -$1.04M | n/m |
| China SXT Pharmaceuticals, Inc. (SXTC) | 2026-03-31 | -$6.21M | n/m |
| Rafael Holdings, Inc. (RFL) | 2025-07-31 | -$30.52M | n/m |
| Neuphoria Therapeutics Inc. (NEUP) | 2026-06-30 | -$13.45M | n/m |
| Longeveron Inc. (LGVN) | 2025-12-31 | -$22.70M | n/m |
| Rallybio Corp (RLYB) | 2025-12-31 | -$8.98M | n/m |
Compare DARE, SXTP, STTK, BSPK side by side · Screen every company in Pharmaceutical Preparations ↗